After NPM1 silencing, the differential expression of proteins was ranked from high to low in cisplatin-resistant bladder cancer cells and found that downregulation of CD40 expression was the most obvious (fold change: −2.66), as shown in Table 4. This evidence concerns the gene NPM1 and urinary bladder cancer.